Tag: GSK
Discontinuation of Flovent Inhaler Sparks Concern among Asthma Patients and Physicians
--- Starting January 1, 2024, asthma patients in the United States face the disappearance of the branded asthma inhaler, Flovent, from pharmacy shelves. The discontinuation[more...]
Patients Face Challenges as GSK Discontinues Asthma Inhaler Flovent
Patients who rely on the asthma inhaler Flovent will soon face challenges as GlaxoSmithKline (GSK) discontinues the branded medication and replaces it with an authorized[more...]
